Do elections move markets?
US election years, such as 2024, tend to be good periods for small and mid-cap (SMID) investors as the higher relative domestic exposure of these companies (c.70-80% versus c.50% for the broader S&P) typically benefits performance. Presidential candidates across the political spectrum recognise that a strong economy wins votes and domestic smaller companies – the […]
Obesity drugs: a lifeline for global healthcare systems
Scroll to interact with the digital experience. Not all themes are worth following… Life sciences is one of Sustainable Global Equity’s key investment themes. Read about our other investment themes and how our investment process is designed to capture the best opportunities across global equity markets. Read more Share: 1 https://www.hermes-investment.com/uploads/2024/04/9d035d814164c6c6874974b1eb1a758a/fhl-sustainable-global-equities-2023-march-2024.pdf 2 https://www.hermes-investment.com/uploads/2024/04/9d035d814164c6c6874974b1eb1a758a/fhl-sustainable-global-equities-2023-march-2024.pdf 3 https://www.oecd-ilibrary.org/sites/6cc2aacc-en/index.html?itemId=/content/component/6cc2aacc-en 4 https://www.nature.com/articles/ijo2012114 5 https://www.oecd-ilibrary.org/sites/6cc2aacc-en/index.html?itemId=/content/component/6cc2aacc-en […]
Spectrum Q3 2024: Marvellous medicine
Fast reading While treatments for obesity have dominated the healthcare investment narrative over the past 18 months, they are by no means the only secular growth story. The life sciences industry may be equally well positioned to benefit from longer term structural trends. Biotech companies are innovating at breakneck speed, creating products and processes that […]
Global Equity ESG, H1 2024 Report
Fast reading Recent pushback against ESG integration is nothing new; meanwhile, progress on an ever more structured, rigorous approach to sustainable investing continues apace. Principal adverse impact indicators (PAIs) are useful metrics to demonstrate how investments can negatively affect factors relating to sustainability, from carbon emissions to human rights. We use PAIs to help us […]
Stocks edge upwards as looser policy looms
market snapshot
GEMs Equity Outlook, H2 2024
a supportive backdrop
Will new reforms tackle the ‘Korea discount’?
Fast reading The dominance of ‘chaebols’ – large, family-owned business conglomerates – has contributed to limited protection for minority shareholders in South Korea and, as a result, lower equity valuations. In addition to complex shareholding and ownership structures, other concerns include: sizeable balances of shares sometimes held in treasury; directors having no legal fiduciary duty […]
Why so glum?
Despite some recent volatility, markets are starting to look optimistically at the potential for a soft landing in the US – inflation is falling towards a normalized level, unemployment is up, but still at historically low levels, and the Federal Reserve looks set to embark on a rate-cut cycle. Yet with all this positive data, […]
The road ahead for US equities
How might the US election impact small- and mid-cap companies? Video transcript 2024 has again shown us that anything can happen. In July alone, we experienced the world’s largest computer meltdown, an assassination attempt on Donald Trump and a change of the Democratic Party’s presidential nominee. The historic decision by President Joe Biden to withdraw […]
Equitorial: A practical pathway to net zero
Fast reading There is no silver bullet for investing in the climate transition, however, common to all approaches is the need to understand the challenges and address a range of obstacles. We believe the best solution combines strong historical data with forward-looking tools including scenario analysis, sector decarbonisation pathways, technology curves and projected emissions. Qualitative […]
